Conference Call 8/15/05 - Calypte - 2nd Quarter Results
Statements of Dr. George:
"Much progress has been made."
"Maxim continues to run our facility in Rockville..."
"Sales are in line with projections at historical sales"
Statements of Rick Brounstein:
"Since May lst we have outsourced our BED incidence test."
"All our manufacturing is outsourced."
"Our R&D Costs are likely to decrease in the near term..."
"expected to decrease the operating cost by 1.25 mil per quarter."
"Our inventory is approximately $600,000 and is solely BED incidence tests and HIV 1/2 rapid tests."
Dr. George Comments in Conference Call:
"...sales for July along were $59,000...today we have firm orders ofr $189,000 of BED Assays." ...we anticipate the market to be $5 to 10 million dollars per year..."
"Beginning in August manufacturing BED tests are now outsourced to MML..."
"We have completed the setup for manufacturing in Thailand..."
"Our major sales efforts have been in Asia and Africa...last week Dick Van Maanen...traveled to India...to finalize registrations of the three rapid tests..."
"In Malayasia Aware kits are being shipped for evaluations for Aware..."
"We have been actively engaged and successful in creating new distribution points in the SubSaharan Region..."
"Initial orders have been received from Abcock and Lilymax."
"In Cameroon and Kenyan we have begun field trials as well."
"Calypte will have representation in twelve SubSaharan countries."
"Calypte has appointed Joseph Gianiasis as its distributor in nineteen countries from Morocco to Pakistan..."
"We have put in distribution channels for forty-one countries."
"...we continue to believe to have sales in China in the coming quarters."
"...the first application that Calypte will file with the FDA...our initial request for approval will be for the oral fluid rapid test."
"We had previously announced the signing of a nonbinding MOU...under that agreement we planned to build a manufacturing facility...the length of GFP certification is unpredicatable. In January of this year, Beijing Calypte...we learned that a small biological manufacturing company, currently manufacturing diagnostic tests and holding current GFP certification...we will also acquire the rights...will cut months from getting products to market...this Chinese company has a blood rapid HIV 1/2 test that is currently approved by the SFDA and is being sold in China. That assay and other currently approved assays will be acquired in the acquisition."
"Our people are on site. Manufacturing Equipment has been delivered to the factory."
"We will be ready to begin manufacturing as soon as SFDA approvals have been received."
"..when consummated will allow us to make up most, if not all the time lost during the trials."
Ted Gwynn of Orasure is the accountant.
New BED product coming out.
|
Thread abonnieren
naja, wenigstens muß man nicht mehr alle postings dieses spinners lesen. aber was solls. jedem das seine. mittlerweile ist er zwar noch lästig, aber ernst nehmen tut den eh kein schwein mehr. 